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Here we describe the role of charged amino acids at the catalytic sites of Escherichia coli ATP synthase. There are four positively
chargedandfournegativelychargedresiduesinthevicinityofofE.coliATPsynthasecatalyticsites.Positivechargesarecontributed
by three arginine and one lysine, while negative charges are contributed by two aspartic acid and two glutamic acid residues.
Replacement of arginine with a neutral amino acid has been shown to abrogate phosphate binding, while restoration of phosphate
binding has been accomplished by insertion of arginine at the same or a nearby location. The number and position of positive
charges plays a critical role in the proper and eﬃcient binding of phosphate. However, a cluster of many positive charges inhibits
phosphate binding. Moreover, the presence of negatively charged residues seems a requisite for the proper orientation and
functioning of positively charged residues in the catalytic sites. This implies that electrostatic interactions between amino acids
are an important constituent of initial phosphate binding in the catalytic sites. Signiﬁcant loss of function in growth and ATPase
activity assays in mutants generated through charge modulations has demonstrated that precise location and stereochemical
interactions are of paramount importance.
1.Introduction
A typical 70kg human generates approximately 2.0 million
kg of ATP, the cell’s energy currency, in a 75-year lifespan by
convertingfoodintouseableenergybyoxidation.ATPisgen-
erated by ATP synthase from ADP and inorganic phosphate
(Pi) [1, 2]. ATP synthase is not only the essential means of
cellular energy production in animals but also in plants and
almost all microorganisms. ATP synthase is the ﬁnal enzyme
in the oxidative phosphorylation pathway and is responsible
for ATP synthesis by oxidative or photophosphorylation in
the membranes of bacteria, mitochondria, and chloroplasts.
It is the smallest known biological nanomotor. In order to
synthesize ATP, a mechanical rotation mechanism is used
wheresubunitsrotateatapproximately100timespersecond.
Basic[3] functionalaspectsof ATPsynthaseremain thesame
in both prokaryotes and eukaryotes [4].
Membrane bound F1Fo ATP synthase enzyme is struc-
turally identical and highly conserved among diﬀerent
species. ATP hydrolysis and synthesis occur in the F1 sector,
whereas proton transport occurs through the membrane
embedded Fo [2, 5]. ATP synthesis is the result of proton
gradient-driven clockwise rotation of γ (as viewed from
the outer membrane), while ATP hydrolysis occurs from
anticlockwise rotation of γ-sub unit. Detailed reviews of ATP
synthase structure and function may be found in [6–16].
An u m b e ro fd i s e a s e ss u c ha sL e i g hs y n d r o m e ,a t a x i a ,
Batten’s diseases, Alzheimer’s, angiogenesis, hypertension,
cancer, heart disease, mitochondrial diseases, immune deﬁ-
ciency, cystic ﬁbrosis, diabetes, ulcers, and tuberculosis that
aﬀect both human and animals have been associated with
ATP synthase ([1, 17] and references therein). The presence
of ATP synthase on the surfaces of multiple cell types,
and its involvement in a number of cellular processes,
makes this enzyme an attractive molecular target in the
development of treatments for numerous diseases. [18–21].
One particular way in which ATP synthase can be used
as a therapeutic target is to inhibit it and thereby deprive2 Journal of Amino Acids
abnormal cells of required energy leading to cell death [1,
17, 21, 22].
2. Inhibition of ATP Synthase
A wide range of natural and synthetic products are known to
bind and inhibit ATP synthase [1, 17, 23, 24]. Biochemical
and structural studies of ATP synthase have so far revealed
about ten diﬀerent inhibitor binding sites. A detailed list
of known inhibitors and their actions on ATP synthase are
discussed in reference [1, 17]. The inhibitory eﬀects and the
extent of inhibition on a molar scale are variable among
diﬀerent inhibitors. Some inhibitors prevent synthesis of
ATP but not hydrolysis, or vice versa, while some are
known to inhibit both synthesis and hydrolysis equally. Well-
known inhibitors of ATP synthase are sodium azide (NaN3),
aluminum ﬂuoride (AlFx), scandium ﬂuoride (ScFx), beryl-
lium ﬂuoride (BeFx), dicyclohexylcarbodiimide (DCCD),
and 7-chloro- 4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl)
[11, 24–32]. Less well-known inhibitors of ATP synthase are
peptides such as melittin, melittin-related peptide (MRP),
ascaphin, aurein, caerin, dermaseptin, magainin II, and
polyphenols such as resveratrol, piceatannol, quercetin,
morin, and epicatechin [1, 18, 19, 21, 33–35].
The polyphenol piceatannol is one of the most portent
inhibitors of ATP synthase [19, 22]. The binding site for
polyphenolsisattheinterfaceof α-,β-,andγ-subunitsofthe
F1 sector. X-ray structure shows that the following polyphe-
nol binding pocket residues γGln274, γThr-277, βAla-264,
βVal-265, γAla-270, γThr-273, γGlu-278, γGly-282, and
αGlu-284, are highly conserved among diﬀerent species and
are within 4 ˚ A of the bound polyphenol compounds. Con-
sequently, piceatannol and other inhibitory polyphenols can
form both hydrophobic and nonpolar interactions with the
above residues [22, 36, 37]. We hypothesize that molecular
modulation of both polyphenol-binding pocket residues
and polyphenol structures may synergistically aﬀect ATP
synthase activity and provide additional clues to catalytic site
function.
The βDELSEED-loop of E. coli ATP synthase is known
to be the binding site for several basic amphiphilic α-helical
peptide inhibitors of ATP synthase. Examples are melittin,
melittin-related peptide (MRP), bacterial/chloroplast ATP
synthase ε-subunit, and SynA2 (the synthetic derivative of
cytochrome oxidase). The α-helical basic peptide, melittin,
is composed of 26 residues and is the primary component of
honey bee venom (Apis mellifera). MRP is a 23-residue long
peptide derived from frog skin (Rana tagoi). Both melittin
and MRP are potent inhibitors of ATPase activity of E. coli
ATP synthase [1, 21, 38, 39].
Most ATP synthase inhibitory peptides studied so far are
from anuran (frogs) sources. These antimicrobial peptides
(AMPs) are cationic, between 10 and 50 residues in length,
and frequently include a C-terminal amide group [1, 40–42].
Previous mode of action studies indicate that AMPs appear
to interact with negatively charged phospholipids and then
insert into the bacterial cell membrane or that they may
also move across the cell membrane by passive transport and
there disrupt a number of cellular processes [43].
Lately, it was observed that some of the antimicrobial
eﬀects of amphibian AMPs may be through their inhibitory
eﬀects on ATP synthase [1, 21]. Melittin and other peptide
inhibitors inhibit ATPase activity in a reversible and non-
competitive fashion [38, 39, 44–47]. It is hypothesized that
relatively short antibacterial or anticancer cationic peptides
of approximately 10–30 amino acid residues with α-helical
secondary structure may inhibit ATP synthase through their
binding totheβDELSEEDloop. Forexample,lysine-induced
threepositivechargesofdermaseptinorfourpositivecharges
ofmagaininIIinteractwiththeﬁvenegativechargesofβAsp-
380, βGlu-381, βGlu-384, βGlu-385, or βAsp-386 and result
in the inhibition of ATPase activity.
Of nearly 60 anuran-derived potential antimicrobial/
anticancer peptides, only 13 have been tested for their
inhibitory eﬀects on ATP synthase [1, 21]. It was shown that
MRP (melittin-related peptide) and MRP-amide strongly
inhibited the ATPase activity of ATP synthase and that the
presence of an amide group at the c-terminus of MRP
causeda∼16%increaseininhibitionofATPsynthaseATPase
activity. Whether or not negative charges in the βDELSEED
motif play any role in the structural stability of the catalytic
sites through electrostatic interactions with site residues
remains to be seen.
3. StructuralandFunctionalAspects of
Charged Residues inthe CatalyticSitesof
ATP Synthase
Recent studies have illuminated the role of charged residues
in Pi binding at the catalytic sites. Binding of inorganic
phosphate (Pi) is an important step in the ATP synthase
mechanism which has been extensively studied by biochem-
ical approaches and may be directly coupled to subunit
rotation [2, 11, 25, 48–53]. ATP synthase is the terminal
enzyme of oxidative phosphorylation and photophosphory-
lation that synthesizes ATP from ADP and Pi. The energy for
ATP synthesis comes from the transmembrane movement of
protons down an electrochemical gradient that is generated
by substrate oxidation or by light capture. As protons move
through the interface between the a and c subunits in the
membrane-bound Fo-sector of the enzyme, the free energy is
transduced into mechanical rotation of a group of subunits
(γεc10−14) which comprise the “rotor”. The helical coiled coil
domain of the γ-subunit projects into the central region of
the α3β3 hexagon in the membrane extrinsic F1-sector. The
α3β3 hexagon contains three catalytic sites at α/β interfaces.
The “Stator” subunits b2 and δ function to prevent co-
rotation of α3β3 with the rotor [6, 54–58]. In this paper we
present a detailed description of the catalytic site charged
amino acids, their role in Pi binding, their eﬀects on the
spatial orientation, and eﬀect of their modulation on one
another.
Figure 1 represents the simplest form of ∼530kDa
Escherichia coli ATP synthase containing eight diﬀerent
subunits, namely, α3β3γδεab2c10−15, divided into two sectorsJournal of Amino Acids 3
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Figure 1: Escherichia coli ATP synthase structure: E. coli ATP
synthase enzyme is composed of two sectors, water soluble F1 and
membrane bound Fo. Catalytic activity occurs at the interface of
αβ/subunits of F1 sector which consists of ﬁve subunits (α3β3γδε)
and proton conduction occurs at the Fo sector consisting of three
subunits (ab2c). One of the catalytic binding sites is identiﬁed with
circle at the interface of α/β subunits. This model of E. coli ATP
synthase is reproduced from Weber [6] with permission; copyright
Elsevier.
F1 and Fo.F 1 corresponds to α3β3γδε and Fo to ab2c.
Overall, F1Fo-ATP synthase is structurally and functionally
similar among sources with only a few exceptions such
as in chloroplasts, where there are two isoforms, and in
mitochondria, where there are 7–9 additional subunits. ATP
hydrolysis and synthesis occur on three catalytic sites in the
F1 sector. The γ-subunit is comprised of three α-helices.
Two of these helices form a coiled coil that extend into the
central space of the α3β3 hexagon. In recent nomenclature,
the rotor consists of γεcn, and the stator consists of α3β3δab2.
Current understanding of the F1Fo ATP synthase structure,
function, catalytic mechanism, and its role in human health
and disease has been thoroughly reviewed by Senior’s group
and others [1, 2, 7, 8, 17, 20, 59].
Based on the binding of ATP, ADP, and Pi, the three
catalytic sites located on the F1 sector of ATP synthase are
designated βTP, βDP, and βE by X-ray crystallographers [60,
61]. βE is the empty site into which Pi (inorganic phosphate)
must initially bind for initiation of ATP synthesis. It has been
proposed that the synthesis reaction in the three catalytic
sites do not occur independently but in a consecutive
manner [51]. In this “binding change mechanism”, the three
catalytic sites have diﬀerent aﬃnities for nucleotides at any
given moment. Each catalytic site undergoes conformational
transitions that lead to the following sequence: substrate
binding (ADP and Pi) → ADP phosphorylation → ATP
release. Experimental observations of rotation veriﬁed the
predication made by Boyer [4, 51, 62] that catalysis requires
the sequential participation of the three catalytic sites, with
changing aﬃnity for substrates and products, as it proceeds
through the recurring mechanism, hence the term “binding
change mechanism.” Proton motive force is converted by
Fo to a mechanical rotation of the rotor shaft, which
drives conformational changes of the catalytic domains of
F1 causing synthesis of ATP by phosphorylation of ADP.
Conformational changes in the catalytic sites are connected
to γ-subunit rotation. γ-Subunit rotation in isolated α3β3γ
subcomplex has been observed directly by Yoshida and
KinositawithcolleaguesinJapanandsubsequentlybyseveral
other labs [12, 63–68]. The focus of this paper, the role of
charged residues at the catalytic sites of E. coli ATP synthase,
is a fundamental issue, because catalytic site charged residues
are also relevant to many other ATPases, GTPases, and their
potential application to nanotechnology and nanomedicine
[1, 11, 18, 69].
4. Catalyticand Motor Functionof
ATP Synthase
Determination of catalytic site Pi-binding residues has
allowed a better understanding of the reaction mechanism
of ATP synthesis and hydrolysis, and their relationship to
the mechanical rotation of the γ-subunit. Characteriza-
tion of catalytic site-charged residues can provide essential
understanding in the following possible applications (1)
development of eﬀective modulator (inhibitory/stimulatory)
molecules of ATP synthase catalytic function and (2)
development of catalytic site mutants for biotechnological
applications.
The analysis of charged catalytic sites residues involved
in Pi binding has also helped answer the primary question of
how the enzyme binds ADP and Pi rather than ATP at the
catalytic sites? This is an often overlooked but crucial ques-
tion in the mechanism of ATP synthesis. In active cells, the
cytoplasmic concentrations of ATP and Pi are approximately
in the 2–5mM range, whereas that of ADP is at least 10–
50-fold lower. Equilibrium-binding assays have established
that both ADP and ATP bind to catalytic sites of puriﬁed
F1 and detergent solubilized F1Fo with relatively similar
binding aﬃnities [71–74]. Obviously, a speciﬁc mechanism
must have evolved for selectively binding ADP into catalytic
sites while simultaneously preventing ATP binding during
proton driven rotation and ATP synthesis. One hypothesis
is that during ATP synthesis, the proton gradient-driven
rotation of subunits impels an empty catalytic site to bind Pi
tightly, thus stereochemically precluding ATP binding and,
therefore, selectively favoring ADP binding [7]. A second
fundamental question is how does subunit rotation aﬀect Pi
binding [49–51]? It was shown that Pi binding appears to be
“energy linked”, which entails a linkage to subunit rotation
[56, 75, 76]. Therefore, for formulating a mechanism of
ATP synthesis, it is of paramount importance to understand
the features that determine Pi binding. Moreover, in the
near future, it may be possible to use molecular features
of Pi binding, derived from mutational and biochemical4 Journal of Amino Acids
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Figure 2: Catalytic sites X-ray structure of ATP synthase showing
spatial relationship of charged α and β-subunit residues. The βDP
site in the AlF4
−-inhibited enzyme structure is taken from [61]. E.
coli residue numbering is used. Four positively and four negatively
charged residue in close proximity to the bound phosphate analog
AlF4
− are identiﬁed. Rasmol software [70] was used to generate this
ﬁgure using PDB ﬁle 1H8E [61].
studies, in the development of potent and novel molecular
modulators of ATP synthase.
5. Characterizationof Charged Residuesat
the CatalyticSites
X-ray structural studies and mutagenic analyses of F1 sector,
the catalytic segment of ATP synthase, have so far identiﬁed
four basic residues critical for catalysis, namely, αβLys-
155, βArg-182, Arg-376, and βArg-246. Figure 2 shows the
spatial orientation of these amino acids in close proximity to
bound phosphate analog AlF4
−. E. coli residue numbers are
used throughout. Figure 2 also shows the spatial relationship
between positive and negative charged residues.
Initial studies employed the MgATP- and MgADP-
binding parameters in mutant enzymes βK155Q, βR182K,
βR182Q, βR246A, βR246Q, βR246K, αR376K, and αR376Q.
These studies used ﬂuorimetric analysis with introduced
βTrp-331 as a speciﬁc catalytic site probe, while analysis
of the transition state formation was done using MgADP-
ﬂuoroaluminate and MgADP-ﬂuoroscandium as transition
stateanalogs[77–81].Absentfromtheseanalyseswasadirect
measurement of Pi binding in the mutant enzymes. The
above residues were clearly demonstrated to be involved in
Pi binding with the subsequent application of Pi protection
against NBD-Cl inhibition assays [11, 48, 82–85].
The βLys-155 is part of the Walker A sequence in the
catalytic sites of ATP synthase. X-ray structures of native F1
with bound MgAMPPNP and MgADP [5], of MgADP-BeFx
inhibited F1 [87], of MgADP-AlF4- inhibited F1 representing
the transition state [61], and of MgADP-AlF3 inhibited F1
Table 1: ATPase activity of E. coli membrane bound or puriﬁed F1
enzymes.
Mutationa ATPase activity μmol/min/mg
Wild-type 28.0 (42.0)
Null 0.0013
βK155Q (0.023)
βR182K (0.250)
βR182Q (0.020)
αR376K (0.120)
αR376Q (0.025)
αF291D 0.07
αF291E 0.09
βN243A 0.95
βN243D 0.033
βR246A 0.050 (0.25)
βR246K (0.27)
βR246Q (0.27)
βN243R 0.023
βN243R/βR246A 0.016
αF291R 0.035
αF291R/βR246A 0.52
αF291R/βN243R 0.028
aWild-type, pBWU13.4/DK8; Null, pUC118/DK8. All mutants were
expressed with the βY331W mutation also present, which does not
signiﬁcantly aﬀect growth. Data are means of four to six experiments
each. bMeasured at 37◦C and expressed as μmol ATP hydrolyzed/min/mg
membrane protein. Each individual experimental point is itself the mean of
duplicate assay tubes. Data in parentheses is from puriﬁed F1 ATP synthase.
Data taken from [48, 82–84, 86].
representing the late transition state/early ground state [88]
all show the ε-amino group of βLys-155 very close (≤3 ˚ A)
to the γ-phosphate position. The βK155Q mutant lacks
ATP synthesis and has very low F1-ATPase activity (Table 1).
Previous work had shown that βLys-155 plays a major role
in binding MgATP, particularly at catalytic sites of high
and medium nucleotide aﬃnity, but not in binding MgADP
[77]. βLys-155 is also critical for transition state formation
[79, 80]. The earlier hypothesis that βLys-155 was important
for Pi binding in ATP synthesis [2] was experimentally
conﬁrmed by Pi protection against NBD-Cl inhibition where
Pi binding in the βE catalytic site is abolished in βK155Q.
Therefore, residue βLys-155 is involved at all stages of ATP
synthesis from Pi binding, to the transition state, to MgATP
formation [84].
βArg-182 is another important positively charged
phosphate-binding residue in the catalytic sites of ATP
synthase [84]. Mutants βR182Q and βR182K lack ATP
synthesis activity and have low F1-ATPase activity (Table 1).
Residue βArg-182 had been shown to be involved in MgATP
binding at the site of highest aﬃnity but not in MgADP
binding. Transition state formation is abolished by βR182Q
but retained in βR182K [78]. In this regard, it should
be noted that βR182K F1 does have somewhat higher
ATPase activity (Table 1). βArg-182 was also hypothesized
to be required for Pi binding in ATP synthesis [2], andJournal of Amino Acids 5
this conﬁrmed that both βR182Q and βR182K mutations
abolished Pi binding in the βE site. Therefore, residue βArg-
182 is also involved in all stages of ATP synthesis from Pi
binding through ATP formation [84].
The αArg-376 residue of E. coli ATP synthase has
been described as the “arginine ﬁnger” based on G-protein
literature and was thought to be a required ligand for the
catalytic transition state. Nonetheless, this residue was not
shown to be involved in MgATP or MgADP binding despite
its apparent proximity to the γ-phosphate of MgAMPPNP
in X-ray structures [65, 81]. Movement of this residue in
and out of the catalytic site was inferred and was postulated
to produce the rate acceleration (“positive catalytic coop-
erativity”) linked to subunit rotation and full (“tri-site”)
catalytic site occupancy that is a hallmark of the mechanism
[2]. Signiﬁcant spatial displacements of residue αArg-376
have been noted in X-ray structures representing diﬀerent
reaction intermediates [5, 33, 61, 75, 87, 88]. Consequently,
it was hypothesized that conformational freedom of this
residue likely contributes to its importance in catalysis [87].
The previously hypothesized importance of this residue in
catalysis [2] was conﬁrmed by Pi protection against NBD-
Cl inhibition in which Pi failed to protect αR376Q F1 from
NBD-Cl inhibition. However, just as the αR376K mutant
was able to form the transition state [81], it was also able
to support Pi binding. It is nevertheless strongly impaired
in both ATP synthesis and hydrolysis, which suggests that
this residue has other required function(s) such as in
conformational movements or in H-bonding to other side
chains that are speciﬁc to Arg and not supported by Lys
[11, 84].
βArg-246 is the fourth positively charged residue within
the Pi-binding subdomain of catalytic sites identiﬁed in the
X-ray crystallographic structure (Figure 2)t h a ti si n v o l v e d
in Pi binding. βArg-246 is equivalent to βArg-260 in
mitochondrial F1 and is conserved among all species. Early
random mutagenesis experiments revealed that mutations
βR246H and βR246C impaired oxidative phosphorylation
drastically and reduced ATPase activity in puriﬁed F1 to
∼1% of wild type [89, 90]. Further work showed that these
mutations caused the unisite catalysis parameter KdPi to
change by 4 orders of magnitude, whereas the KdADP was
largelyunalteredbyβR246C,andtheATPhydrolysisreaction
equilibrium constant changed to favor ATP over ADP plus
Pi [91]. Computer simulations have drawn attention to
βArg-246, where movement of the residue during rotation,
conformationalchangeofthesites[92],andaroleinbinding
Pi in the transition state were predicted [93, 94]. Site-
directed mutagenesis of βR246 to Gln, Lys, and Ala was
used to examine the eﬀects of each mutation on function.
A variety of inhibitors and ligands known to bind or react
in the catalytic sites close to the Pi-binding subdomain were
utilizedincombinationwiththemutantenzymestoestablish
the role of the βArg-246 side chain. Substitutions of the Arg
side chain to Gln (removes charge and preserves bulk), to
Lys (preserves positive charge), and to Ala (removes side
chain and charge) were all examined. All three substitutions
severely impeded growth by oxidative phosphorylation and
reduced ATPase activity of puriﬁed F1 to ∼1% of wild type.
Finally, as shown in Figure 3 Pi protection against NBD-
Cl inhibition clearly demonstrated that βArg-246 residue
side chain is an important constituent in binding Pi and in
forming the transition state [48].
Pi binding assays using Pi protection against NBD-Cl
were devoid of any nucleotide and enzymes were prepared so
astohaveallthreecatalyticsitesessentiallyempty.Therefore,
the sites were in βE conformation. In this conformation
αArg-376 and βArg-246 lie 2.6 and 4.0 ˚ Af r o mβArg-182,
whereas βLys-155 lies 9.5, 7.3, and 6.3 ˚ Af r o mαArg-376,
βArg-182, and βArg-246, respectively [88]. In essence, the
X-ray structure [87] showed that bound MgADP-BeFx
mimicked bound MgATP. In assays of F1-ATPase, it was
shown that wild type and αR376Q were fully inhibited by
MgADP-BeFx, whereas βK155Q and βR182Q were fully-
resistant (Z. Ahmad, and A. E. Senior, unpublished work).
These results supported the hypothesis that βLys-155 and
βArg-182 are MgATP ligands, but that αArg-376 is not, and
that the involvement of stringent stereochemical orientation
factorsplaysaroleindeterminingthefunctionalinteractions
of αArg-376 [11, 84].
The four positively charged residues form a tetrahedral
structure with βLys-155 at the apex and αArg-376, βArg-
182, and βArg-246 on the base [11, 25]. A potential Pi-
binding pocket can readily be envisaged at the center of
this tetrahedron (see Figure 2). In ATP synthesis, the βE
site will change to the βADP + Pi (“half-closed”) site in
association with γ-rotation [2, 61]. The X-ray structure of
this conformation [61] shows that the residues αArg-376,
βLys-155, and βArg-182 are each located ≤3.0 ˚ A from the
nearest oxygen atom of bound SO4
2−) anion (modeling
Pi), whereas βArg-246 is 4.5 ˚ A from the sulfate. Thus, as
the reaction proceeds, the three residues αArg-376, βLys-
155 and βArg-182 close around the Pi and move it away
from βArg-246 toward the site of transition state formation
[11, 12, 48, 95].
The above results supported the following proposed
molecular mechanism for ATP synthesis [2]. Initially, sub-
stratePibindsintheβEcatalyticsiteusingfourbasicresidues
asligands,namely,αArg-376,βArg-182,βLys-155,andβArg-
246 [11, 25, 48, 82–84, 86]. After binding of MgADP (in
which these four residues are not involved), the catalytic
transition state forms using αArg-376, βArg-182, and βLys-
155 as direct ligands. Upon formation of MgATP, αArg-
376 withdraws and no longer interacts, whereas βLys-155
and βArg-182 are still bound to the γ-phosphate. MgATP is
released to the medium with the breaking of these bonds.
Historically, many attempts to measure Pi binding in
puriﬁed E. coli F1 using [32P] Pi [50] or by competition
with ATP or AMP-PNP in ﬂuorescence assays of nucleotide
binding [72, 96] failed to detect appreciable Pi binding at
physiological Pi concentration. An assay devised by Perez et
al. [97] in which the protection aﬀorded by Pi against the
inhibition of ATPase activity was induced by covalent reac-
tion with 7-chloro-4-nitrobenzo-2-oxa-1, 3,-diazole (NBD-
Cl) provided a measure of Pi binding. Orriss et al. [98]
showed by X-ray crystallography that the covalent adduct
formed by NBD-Cl is speciﬁcally in the βE catalytic site.
Hence, protection aﬀorded by Pi indicates that binding of Pi6 Journal of Amino Acids
DVSAFVPTNVISITDGQIFLETNLFNAG I RPAVNPGISVSRVGGAAQTKIMKKLSGGIRTALAQYRELAAFSQFASDLD
DVSAFVPTNVISITDGQIFLESNLFNAGIRPAVNPGISVSRVGGAAQTKIMKKLSGGIRTALAQYRELAAFSQFASDLD
DVSAYIPTNVISITDGQIFLEAELFYKGIRPAINVGLSVSRVGSAAQVKALKQVAGS LKLFLAQYREVAAFAQFGSDLD
DVSAYVPTNVISITDGQIFLESELFYKGFRPAVNIGLSVSRVGSAAQLKSVKKVAGS IKLSLAQYRELEDFAKFGSDLD
DVSAYVPTNVISITDGQIFLESELFYKGFRPAVNIGLSVSRVGSAAQLKSVKKVAGS IKLSLAQYRELEDFAKFGSDLD
DVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAAQTRAMKQVAGTMKLELAQYREVAAFAQFGSDLD
DVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAAQTRAMKQVAGTMKLELAQYREVAAFAQFGSDLD
DVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAAQTRAMKQVAGTMKLELAQYREVAAFAQFGSDLD
DVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAAQTRAMKQVAGTMKLELAQYREVAAFAQFGSDLD
DVSAYIPTNVISITDGQIFLETELFYKGIRPAINVGLSVSRVGSAAQTRAMKQVAGTMKLELAQYREVAAFAQFGSDLD
336 (E. coli residue numbers) 414
E. coli
Salmonella
Saccharomyces
Drosophila
Salmo
Xenopus
Rattus
Bos
Homo
Gallus
(a)
MMELIRNIAIEHSGYSVFAGVGERTREGNDFYHEMTDSNVID-------KVSLVYGQ M NEPPGNRLRVALTGLTMAEKFRD-
VLLFVDNIYRYTLAGTE
MMELIRNIAIEHSGYSVFAGVGERTREGNDFYHEMTDSNVID-------KVSLVYGQ M NEPPGNRLRVALTGLTMAEKFRD-
VLLFVDNIYRYTLAGTE
IQELIN NIA KAHGGF SVFTGVGERTREGNDLYREMKETGVINLEG--
ALVFGQ M NEPPGARARVALTGLTIAEYFRDEEGQDVLLFIDNIFRFTQAGSE
IMELIN N V A KAHGGYSVFAGVGERTREGNDLYNEMIEGGV I SLKD-
VALVYGQMNEPPGARARVALTGLTVAEYFRDQEGQDVLLFIDNIFRFTQAGSE
IMELIN N V A KAHGGYSVFAGVGERTREGNDLYHEMIE SGVINLKD-
VALVYGQMNEPPGARARVALTGLTVAEYFRDQEGQDVLLFIDNIFRFTQAGSE
MMELIN NIA KAHSGLSVFAGVGERTREGNDFYHEMADSGVVNLENLGE SKVSM VYGQ M NEPPGNRLRVALTGLTIAE SFRD-
VLFFVDNIYRYTLAGTE
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Figure 3: Sequence alignment of α and β-subunit residues. α and β-subunit amino acids from diﬀerent species are aligned. Conserved
positively charged residues are shown in blue color, and negatively charged residues are identiﬁed by red color. E. coli starting residue
for α-subunit is αD336 and for β-subunit is βK155.
occurs at the βE catalytic site. By modifying the above assay
for use with E. coli puriﬁed F1 or membrane bound F1Fo,
further studies have to date investigated the relationship
between Pi binding and catalysis for eight residues, namely
αPhe-291, αSer-347, αGly-351, αArg-376, βLys-155, βArg-
182, βAsn-243, and βArg-246. It was shown that the ﬁve
residues αSer-347, αArg-376, βLys-155, βArg-182, and βArg-
246 were grouped in a tetrahedral relationship,and are
involved in Pi binding. The other three residues αPhe-291,
αGly-351, and βAsn-243 are not involved in Pi binding
[11, 25, 48, 82–84, 86]. In consequence, the presence of
positively charged residues in the catalytic site explains the
preferential binding of ADP over ATP.
It may be noted that [32P]Pi binding was detected with a
Kd(Pi) in the range of 0.1mM using an alternative, pressure
ultraﬁltration method, and this result is consistent with
data obtained from the NBD-Cl protection assay [99]. It
is apparent that Pi dissociates more rapidly from E. coli F1
than it does from mitochondrial F1, undesirably, rendering
the convenient centrifuge assay incompatible with the E. coli
enzyme.
The story goes on with the presence of many
charged/uncharged residues in close proximity to the
Pi binding subdomain in the catalytic sites. These residues
have been shown to exert either a direct or an indirect role in
Pi binding. One of these residues is the charged αAsp-350 of
the VISIT-DG sequence. αAsp-350 is part of the α-subunit
VISIT-DG sequence, which is a highly conserved motif
in this enzyme [25]. VISIT-DG sequence residues are of
special interest in general and negatively charged αAsp-350
in particular, because of the close proximity to the known
positively charged phosphate-binding residues. αAsp-350 is
∼3 ˚ Af r o mαArg-376. It would be imperative to understand
three speciﬁc aspects of αAsp-350 residue. First, is residue
Asp-350 directly or indirectly involved in phosphate binding
through αArg-376? Second, is αAsp-350 important for
function through its role in maintaining the structural
integrity of the Pi binding subdomain but not involved in Pi
binding per se? Third, is the carboxyl side chain of αAsp-350
involved in the transition state at the catalytic site? Our
hypothesis is that αAsp-350 interacts electrostatically with
αR376. Such an interaction may provide proper orientation
of αArg-376 side chain towards Pi.
6. Modulation of Charge in the CatalyticSites
Understanding the role of charged residues and the eﬀects of
modifying them is important in understanding the molecu-
lar mechanism of ATP synthesis. NBD-Cl inactivation assay
described earlier have shown that positively charged residues
are functionally essential for Pi binding in the βE catalytic
site of E. coli ATP synthase [11, 48, 83, 84]. The introductionJournal of Amino Acids 7
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Figure 4: Compensatory eﬀect inserted arginine residue. Membranes were preincubated with Pi at zero, 2.5 or 10mM concentration as
shown, for 60min at 23◦C. Then, NBD-Cl (125μM) was added and aliquots withdrawn for assay at time intervals as shown. ATPase activity
remaining is plotted against time of incubation with NBD-Cl.  , no Pi added; , 2.5mM Pi; Δ,1 0m MP i .D a t at a k e nf r o m[ 83].
of charged residues in place of uncharged residues in the
vicinity of catalytically important residues has been shown
to aﬀect Pi binding by resulting in a loss or gain of ATPase
activity [82, 83, 86]. Earlier work [82, 83] indicated that the
introduction of negative charge in the Pi-binding pocket in
the form of βN243D close to βArg-246 prevented Pi binding
(Figure 5). Also, introduction of positive charge in the form
ofβN243RrestoredPibindinginβR246Amutants.Similarly,
the introduction of negative or positive charge in the form
of αF291D/E/R with βR246 or βR246A resulted in a loss
or gain of Pi binding (Figures 4 and 5)[ 83, 86]. These
results suggested that modulation of charge in the Pi binding
site could be used to understand the molecular mechanism
of Pi binding. It is established that Arg residues occur
particularly commonly in the Pi binding sites of proteins
[100]. Therefore, varying the number of Arg residues in8 Journal of Amino Acids
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Figure 5: Loss of Pi protection from inactivation by NBD-Cl inhibition with inserted negative charge. Membranes were preincubated with Pi
at zero, 2.5 or 10mM concentration as shown, for 60min at 23◦C. Then, NBD-Cl (125μM) was added and aliquots withdrawn for assay at
time intervals as shown. ATPase activity remaining is plotted against time of incubation with NBD-Cl.  ,n oP ia d d e d ;, 2.5mM Pi; Δ,
10mM Pi. Data taken from [82, 86].
the Pi binding site of ATP synthase can be an instructive
approach.
Residue βAsn-243 lies 3.2 ˚ Af r o mβArg-246 in both
AlF3 and SO4
2−)-containing catalytic sites (nearest atom
distances quoted) [83]. One experimental approach used
was to introduce the mutation βN243R in a wild-type
background (with βArg-246) and in presence of the βR246A
mutation. Residue αPhe-291, located at the end of the
Pi-binding pocket across the catalytic α/β interface, with its
side-chain pointing toward the bound Pi analogs, is also a
suitable location for introducing a new Arg. This residue lies
at a distance of 3.2 ˚ Af r o mβArg-246 in the AlF3-containing
catalytic site and 7.5 ˚ A in the SO4
2−-containing catalytic
site [61, 83, 88]. Arginine was introduced in the form of an
αF291R mutation in the wild-type background and in the
presence of the βR246A mutation. The actual distances of
residues βArg-246, βAsn-243 and αPhe-291 were obtained
from bound AlF3 and SO4
2− as determined by X-ray
crystallography [61, 88], while speculative distances (in
brackets) were calculated for mutant residues βAla-246,
βArg-243 and αArg-291 using the “Deep View Swiss-Pdb
Viewer” [101]. Apparently, mutations placed extra positive
charge relatively close to Pi, and the βAla-246 mutation
left a relatively large space into which a new Arg ﬁts nicely.
7. SynergisticStereochemical Interactionsat
the CatalyticSites
The introduction of one or two extra positively charged Arg
residues in the wild-type background at either β-243 or α-
291, or both, has proven to inhibit Pi binding (Figure 4).
Introduction of a new Arg at β-243 or α-291 in the βR246A
background provided a signiﬁcant compensatory eﬀect on
ATPase. ATP-driven proton pumping was also reinstated
in the case of the αF291R/βR246A mutant. But these new
arginines did not restore function to full normal [83].
The βR246A mutant did not show Pi binding, but both
βN243R and αF291R mutations “rescued” Pi binding in
combination with βAla-246 (Figure 4). Since neither βArg-
243 nor αPhe-291 could be expected to assume the exact
same stereochemical interactions that βArg-246 achieves,
electrostatic interaction appears to be a signiﬁcant factor.
Presenceofatleastonepositivechargeatthisgenerallocation
is a requisite determinant of initial Pi binding in the catalytic
site βE. βN243R or αF291R in the wild-type backgroundJournal of Amino Acids 9
(representing one extra positive charge) did not prevent
Pi binding, but the combination of αF291R/βN243R (two
extra charges) abrogated Pi binding (Figure 4). Presumably
the local concentration of charge in the latter becomes too
disruptive and distorts the Pi-binding site [83].
A similar pattern of eﬀects has been reported when tran-
sition state stabilization was assessed by assaying inhibition
of ATPase activity by the transition state analogs MgADP-
ﬂuoroaluminate and MgADP-ﬂuoroscandium. Previously,
it was shown that [48] that both inhibitors are potent
against wild-type ATP synthase but that each inhibit βR246A
mutant only to small extent, which indicates that βArg-
246 is intimately involved in transition state stabilization. It
was found that either mutant residue βArg-243 or αArg-291
partly “rescued” transition state stabilization when present
withβAla-246[83].Raisingthenumberofpositivelycharged
residues to two (βN243R and αF291R mutants in wild-type
background) had an adverse eﬀect as reﬂected by a lesser
inhibition of ATPase activity. Raising the number of local
positivechargestothreereducedtransitionstatestabilization
right back to where it was in βR246A. Interestingly, even
in the best cases among the mutants (βN243R/βR246A or
αF291R/βR246A) transition state stabilization was incom-
plete as compared to wild-type, which suggests the impor-
tance of stereochemical interactions [83].
In summary, all the results showed that Pi binding is
notably aﬀected by the local positive charges in catalytic site
βE of ATP synthase. Positive charge in the vicinity of the nat-
ural βArg-246 is important because its removal in βR246A
mutant can be compensated partially by introduction of one
Arg at either β-243 or α-291. Thus, electrostatic interaction
is an important determinant of Pi binding. The presence of
two arginines by introduction of either βArg-243 or αArg-
291 in the presence of βArg-246 does not prevent Pi binding,
but the presence of all three arginines eliminates Pi binding.
Eﬀects on transition state stabilization followed a parallel
pattern, but the restoration of Pi binding in βE catalytic sites
by charge compensation was not suﬃcient by itself to restore
full function [83].
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